Skip to main content
Article thumbnail
Location of Repository

CONTINUING EDUCATION Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology*

By Pieter L. Jager, Willem Vaalburg, Jan Pruim, Elisabeth G. E. De Vries, Karl-josef Langen and D. Albertus Piers


As the applications of metabolic imaging are expanding, radiolabeled amino acids may gain increased clinical interest. This review first describes the basic aspects of amino acid metabolism, then continues with basic aspects of radiolabeled amino acids, and finally describes clinical applications, with an emphasis on diagnostic value. A special focus is on 11C-methio nine, 11C-tyrosine, and 123I-iodomethyltyrosine, because these have been most used clinically, although their common affinity for the L-transport systems may limit generalization to other classes of amino acids. The theoretic and preclinical background of amino acid imaging is sound and supports clinical applications. The fact that amino acid imaging is less influenced by inflammation may be advantageous in comparison with 18F-FDG PET imaging, although tumor specificity is not absolute. In brain tumor imaging, the use of radiolabeled amino acids is established, the diagnostic accuracy of amino acid imaging seems adequate, and the diagnostic value seems advantageous. The general feasibility of amino acid imaging in other tumor types has sufficiently been shown, but more research is required in larger patient series and in well-defined clinical settings. Key Words: radiolabeled amino acids; 11C-methionine; 11C-tyrosine; 123I-iodo-�-methyltyrosine; tumor imagin

Topics: J Nucl Med 2001, 42, 432–445
Year: 2000
OAI identifier: oai:CiteSeerX.psu:
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.